Despite evidence linking PAK signalling to immune regulation and vascular dynamics [14,30], the effects of PAK1 and PAK4 on tumour vasculature and chemotherapy response in PDA remain poorly defined. The gene discussed is PAK1; the disease is Patent ductus arteriosus.